Coronavirus Spike Glycoprotein (CoV S) peptide (Cy5)
Aperçu rapide pour Coronavirus Spike Glycoprotein (CoV S) peptide (Cy5) (ABIN6952489)
Antigène
Origine
Source
Application
-
-
Purification/Conjugué
- This Coronavirus Spike Glycoprotein peptide is labeled with Cy5.
-
Séquence
- Cy5-SLDQINVTFL DLEYEMKKLE EAIKKLEESY IDLKEL
-
Attributs du produit
- EK1 / Pan-HCoV S Inhibitor - Cy5 Labeled
-
Pureté
- ≥ 90 %
-
Ingrédients
- Each vial contains 1 nmol of NET labeled peptide.
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Powder
-
Stock
- 4 °C
-
Stockage commentaire
- Store in dry form in a dark place with temperature 0-5°C.
-
-
-
: "Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein." dans: Cellular & molecular immunology, (2020) (PubMed).
: "Drug treatment options for the 2019-new coronavirus (2019-nCoV)." dans: Bioscience trends, Vol. 14, Issue 1, pp. 69-71, (2020) (PubMed).
: "A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike." dans: Science advances, Vol. 5, Issue 4, pp. eaav4580, (2019) (PubMed).
-
: "Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein." dans: Cellular & molecular immunology, (2020) (PubMed).
-
- Coronavirus Spike Glycoprotein (CoV S)
-
Classe de substances
- Viral Protein
-
Poids moléculaire
- 4332
Antigène
-